Improving TCR T-Cell Persistence and Efficacy with Adaptimmune's Dennis Williams
Cell & Gene: The Podcast
00:00
Navigating Challenges in the FDA Approval Process for Cancer Therapy
This chapter explores the FDA's accelerated approval of Adaptimmune's Teslera for metastatic synovial sarcoma, detailing Phase Two trial results and clinical challenges. It also addresses the socioeconomic factors influencing the trial, including the impact of the COVID pandemic and the historical treatment landscape for this rare disease.
Transcript
Play full episode
